An open-label study to analyze the effect on response and disease progression of capecitabine (Xeloda) in metastatic colorectal cancer patients with regard to the expression profile of key enzymes in the capecitabine metabolism.
Phase of Trial: Phase II
Latest Information Update: 29 May 2010
At a glance
- Drugs Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 02 Jun 2006 New trial record.